Nothing Special   »   [go: up one dir, main page]

Latest News for: Gilead Sciences

Edit

CAR T-Cell Therapy For Acute Lymphoblastic Leukemia Treatment Market 2034: EMA, PDMA, FDA Approvals, Prevalence, ...

GetNews 06 Feb 2025
CAR T-Cell Therapy For Acute Lymphoblastic Leukemia Companies are Gilead Sciences, Novartis, Autolus Therapeutics, Cellectis, Guangzhou Bio-gene Technology, ... Gilead Sciences KYMRIAH (tisagenlecleucel).
Edit

Statement of Changes in Beneficial Ownership (Form 4) (Gilead Sciences Inc)

Public Technologies 06 Feb 2025
) FORM 4. Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b) ... See Instruction 10 ... 2 ... GILEAD SCIENCES, INC ... GILEAD SCIENCES, INC., 333 LAKESIDE DRIVE 3 ... GILEAD SCIENCES, INC ... Gilead Sciences Inc.
Edit

Thermo Fisher Scientific Accelerates 100 Percent Renewable Electricity Goal for European Operations with New Solar Power Agreement with X-ELIO

Pharmiweb 05 Feb 2025
The aggregated share of Lorca solar will simultaneously reduce Scope 2 and Scope 3 emissions for Thermo Fisher and the cohort of value chain partners—GSK, Gilead Sciences and Haleon—who participated ...
Edit

Gilead Submits Marketing Authorization Applications to European Medicines Agency for Twice-Yearly Lenacapavir for HIV Prevention (Gilead Sciences Inc)

Public Technologies 04 Feb 2025
Foster City, Calif., February 3, 2025 - Gilead Sciences, Inc ... For more information about Gilead, please visit the company's website at www.gilead.com, follow Gilead on X/Twitter (@Gilead Sciences) and LinkedIn (@Gilead-Sciences) ... Gilead Sciences Inc.
Edit

Global Oral Controlled Release Drug Delivery Technology Market is anticipated to reach USD 84.2 Billion by 2035

Pharmiweb 04 Feb 2025
Oral Controlled Release Drug Delivery Technology Market ... According to market projections, the industry will expand at a compound annual growth rate (CAGR) of 7.2% over the forecast period (2025–2035) ... Inc ... F ... Sun Pharmaceuticals BioNTech Gilead Sciences.
Edit

Marginal Zone Lymphoma Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | ...

GetNews 03 Feb 2025
Bristol-Myers Squibb, TG Therapeutics, Gilead Sciences, AstraZeneca, Nordic Nanovector, Christian Buske, AbbVie, Pharmacyclics LLC, Hutchison Medipharma, Beigene, Incyte Corporation, Enterome, and others ... Gilead Sciences.
Edit

We have a shot at ending HIV — don’t let politics get in the way

The Hill 01 Feb 2025
lenacapavir, recently named Science Magazine's 2024 "Drug of the Year.". Lenacapavir, developed by Gilead Sciences, represents a groundbreaking leap in HIV prevention ... First, Gilead should expand its licensing agreement to include all countries.
Edit

Topical Mupirocin Lowers Lupus Inflammation

Mega Doctor News 30 Jan 2025
Mega Doctor News ... J ... Aditum Bio; Anaptys Bio; AstraZeneca, PLC; Biogen; EMD Serono; Exo Therapeutics; Gilead Science, Inc.; GSK; Lilly, Eli, and Company; Lupus Research Alliance; Related Science, LLC; Rome Therapeutics; Synthekine; Ventus Therapeutics.
Edit

Woman prosecuted in Oregon in $4M scheme to smuggle and prescribe unapproved drug for fatal ...

The Oregonian 24 Jan 2025
The antiviral drug GS-441524 was developed and patented by the California-based Gilead Sciences, the biopharmaceutical company known for its antiviral drugs to treat HIV/AIDS, hepatitis B and C, influenza and COVID-19.
Edit

Biotechnology Market Size, Share, Trends Research Report 2025-2034

Pharmiweb 24 Jan 2025
Author Company. Cervicorn Consulting Author Name. Sahil Rane Author Email. sahilrane2530@gmail.com Author Telephone. +917499931916 Author Website. https.//www.cervicornconsulting.com/ ... Key Players in the Biotechnology Market Amgen Inc. Gilead Sciences, Inc.
Edit

Myelodysplastic Syndrome Therapeutics Market Size in the 7MM was ~USD 2,800 Million in 2023, is ...

GetNews 21 Jan 2025
The leading Myelodysplastic Syndrome Companies such as Bristol-Myers Squibb, Astex Pharmaceutical, Taiho Oncology, Fibrogen, AbbVie, Gilead Sciences, Novartis, Syros Pharmaceuticals, Takeda, Pfizer, ...
Edit

Chronic Lymphocytic Leukemia Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight ...

GetNews 20 Jan 2025
Hoffmann-La Roche Ltd, AstraZeneca, Secura Bio, Inc, Novartis AG, AbbVie, Inc., Gilead Sciences, Inc., BeiGene, Inc., Sanofi (Genzyme Corporation), Ziopharm Oncology Inc, Ono pharmaceuticals Co Ltd, Teva Pharmaceutical Industries, and others.
Edit

Best blue-chip ETFs to buy for a SWAN and rich retirement

Invezz 17 Jan 2025
Investing in quality blue-chip ETFs can be a great way to ensuring a rich retirement ... VOO vs IBIT vs MOAT vs COWZ ... Some of the most notable members of the portfolio are names like Alphabet, Disney, Bristol-Myers Squibb, Gilead Sciences, and Teradyne.

Most Viewed

×